Global Veterinary Genetic Engineering Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Veterinary Genetic Engineering Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Veterinary Genetic Engineering Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Veterinary Genetic Engineering Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Veterinary Genetic Engineering Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Veterinary Genetic Engineering Vaccines players cover Merck, GSK, Sanofi, Zoties, Elanco, Boehringer Ingelheim, Indian Immunologicals, China Animal Husbandry Industry Co.,Ltd. and Yebio Bioengineering Co., Ltd Of Qingdao, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Veterinary Genetic Engineering Vaccines Industry Forecast” looks at past sales and reviews total world Veterinary Genetic Engineering Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Genetic Engineering Vaccines sales for 2023 through 2029. With Veterinary Genetic Engineering Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Genetic Engineering Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Genetic Engineering Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Genetic Engineering Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Veterinary Genetic Engineering Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Genetic Engineering Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Genetic Engineering Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Genetic Engineering Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Veterinary Genetic Engineering Vaccines market?
What factors are driving Veterinary Genetic Engineering Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Genetic Engineering Vaccines market opportunities vary by end market size?
How does Veterinary Genetic Engineering Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Veterinary Genetic Engineering Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Veterinary Genetic Engineering Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Veterinary Genetic Engineering Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Veterinary Genetic Engineering Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Veterinary Genetic Engineering Vaccines players cover Merck, GSK, Sanofi, Zoties, Elanco, Boehringer Ingelheim, Indian Immunologicals, China Animal Husbandry Industry Co.,Ltd. and Yebio Bioengineering Co., Ltd Of Qingdao, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Veterinary Genetic Engineering Vaccines Industry Forecast” looks at past sales and reviews total world Veterinary Genetic Engineering Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Genetic Engineering Vaccines sales for 2023 through 2029. With Veterinary Genetic Engineering Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Genetic Engineering Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Genetic Engineering Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Genetic Engineering Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Veterinary Genetic Engineering Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Genetic Engineering Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Genetic Engineering Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Genetic Engineering Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Genetic Recombinant Vaccine
- Recombinant Subunit Vaccines
- Genetic Vaccine
- Poultry
- Livestock
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GSK
- Sanofi
- Zoties
- Elanco
- Boehringer Ingelheim
- Indian Immunologicals
- China Animal Husbandry Industry Co.,Ltd.
- Yebio Bioengineering Co., Ltd Of Qingdao
- Jinyu Bio-technology Co.,ltd.
- HVRI
- Ringpu Biology
- Kyoto Biken Laboratories
- FATRO
- Ceva Sant? Animale
- Pulike Biological Engineering,Inc.
- Wuhan Hvsen Biotechnology CO.,LTD
- Jinhe Biotechnology Co., Ltd.
- Shanghai Shen Lian Biomedical Corporation
- Qingdao Vland Biotech INC.
What is the 10-year outlook for the global Veterinary Genetic Engineering Vaccines market?
What factors are driving Veterinary Genetic Engineering Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Genetic Engineering Vaccines market opportunities vary by end market size?
How does Veterinary Genetic Engineering Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Veterinary Genetic Engineering Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Veterinary Genetic Engineering Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Veterinary Genetic Engineering Vaccines Segment by Type
2.2.1 Genetic Recombinant Vaccine
2.2.2 Recombinant Subunit Vaccines
2.2.3 Genetic Vaccine
2.3 Veterinary Genetic Engineering Vaccines Sales by Type
2.3.1 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Veterinary Genetic Engineering Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Type (2018-2023)
2.4 Veterinary Genetic Engineering Vaccines Segment by Application
2.4.1 Poultry
2.4.2 Livestock
2.4.3 Other
2.5 Veterinary Genetic Engineering Vaccines Sales by Application
2.5.1 Global Veterinary Genetic Engineering Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Veterinary Genetic Engineering Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Application (2018-2023)
3 GLOBAL VETERINARY GENETIC ENGINEERING VACCINES BY COMPANY
3.1 Global Veterinary Genetic Engineering Vaccines Breakdown Data by Company
3.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Veterinary Genetic Engineering Vaccines Revenue by Company (2018-2023)
3.2.2 Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Company
3.4 Key Manufacturers Veterinary Genetic Engineering Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Genetic Engineering Vaccines Product Location Distribution
3.4.2 Players Veterinary Genetic Engineering Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VETERINARY GENETIC ENGINEERING VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Genetic Engineering Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Veterinary Genetic Engineering Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Veterinary Genetic Engineering Vaccines Sales Growth
4.4 APAC Veterinary Genetic Engineering Vaccines Sales Growth
4.5 Europe Veterinary Genetic Engineering Vaccines Sales Growth
4.6 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Growth
5 AMERICAS
5.1 Americas Veterinary Genetic Engineering Vaccines Sales by Country
5.1.1 Americas Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023)
5.1.2 Americas Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023)
5.2 Americas Veterinary Genetic Engineering Vaccines Sales by Type
5.3 Americas Veterinary Genetic Engineering Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Genetic Engineering Vaccines Sales by Region
6.1.1 APAC Veterinary Genetic Engineering Vaccines Sales by Region (2018-2023)
6.1.2 APAC Veterinary Genetic Engineering Vaccines Revenue by Region (2018-2023)
6.2 APAC Veterinary Genetic Engineering Vaccines Sales by Type
6.3 APAC Veterinary Genetic Engineering Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Genetic Engineering Vaccines by Country
7.1.1 Europe Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023)
7.1.2 Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023)
7.2 Europe Veterinary Genetic Engineering Vaccines Sales by Type
7.3 Europe Veterinary Genetic Engineering Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Genetic Engineering Vaccines by Country
8.1.1 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Type
8.3 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Genetic Engineering Vaccines
10.3 Manufacturing Process Analysis of Veterinary Genetic Engineering Vaccines
10.4 Industry Chain Structure of Veterinary Genetic Engineering Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Genetic Engineering Vaccines Distributors
11.3 Veterinary Genetic Engineering Vaccines Customer
12 WORLD FORECAST REVIEW FOR VETERINARY GENETIC ENGINEERING VACCINES BY GEOGRAPHIC REGION
12.1 Global Veterinary Genetic Engineering Vaccines Market Size Forecast by Region
12.1.1 Global Veterinary Genetic Engineering Vaccines Forecast by Region (2024-2029)
12.1.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Genetic Engineering Vaccines Forecast by Type
12.7 Global Veterinary Genetic Engineering Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.1.3 Merck Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.2.3 GSK Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.3.3 Sanofi Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Zoties
13.4.1 Zoties Company Information
13.4.2 Zoties Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.4.3 Zoties Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zoties Main Business Overview
13.4.5 Zoties Latest Developments
13.5 Elanco
13.5.1 Elanco Company Information
13.5.2 Elanco Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.5.3 Elanco Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Elanco Main Business Overview
13.5.5 Elanco Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Indian Immunologicals
13.7.1 Indian Immunologicals Company Information
13.7.2 Indian Immunologicals Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.7.3 Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Indian Immunologicals Main Business Overview
13.7.5 Indian Immunologicals Latest Developments
13.8 China Animal Husbandry Industry Co.,Ltd.
13.8.1 China Animal Husbandry Industry Co.,Ltd. Company Information
13.8.2 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.8.3 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 China Animal Husbandry Industry Co.,Ltd. Main Business Overview
13.8.5 China Animal Husbandry Industry Co.,Ltd. Latest Developments
13.9 Yebio Bioengineering Co., Ltd Of Qingdao
13.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
13.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Main Business Overview
13.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
13.10 Jinyu Bio-technology Co.,ltd.
13.10.1 Jinyu Bio-technology Co.,ltd. Company Information
13.10.2 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.10.3 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jinyu Bio-technology Co.,ltd. Main Business Overview
13.10.5 Jinyu Bio-technology Co.,ltd. Latest Developments
13.11 HVRI
13.11.1 HVRI Company Information
13.11.2 HVRI Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.11.3 HVRI Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 HVRI Main Business Overview
13.11.5 HVRI Latest Developments
13.12 Ringpu Biology
13.12.1 Ringpu Biology Company Information
13.12.2 Ringpu Biology Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.12.3 Ringpu Biology Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ringpu Biology Main Business Overview
13.12.5 Ringpu Biology Latest Developments
13.13 Kyoto Biken Laboratories
13.13.1 Kyoto Biken Laboratories Company Information
13.13.2 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.13.3 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Kyoto Biken Laboratories Main Business Overview
13.13.5 Kyoto Biken Laboratories Latest Developments
13.14 FATRO
13.14.1 FATRO Company Information
13.14.2 FATRO Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.14.3 FATRO Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 FATRO Main Business Overview
13.14.5 FATRO Latest Developments
13.15 Ceva Sant? Animale
13.15.1 Ceva Sant? Animale Company Information
13.15.2 Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.15.3 Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Ceva Sant? Animale Main Business Overview
13.15.5 Ceva Sant? Animale Latest Developments
13.16 Pulike Biological Engineering,Inc.
13.16.1 Pulike Biological Engineering,Inc. Company Information
13.16.2 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.16.3 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Pulike Biological Engineering,Inc. Main Business Overview
13.16.5 Pulike Biological Engineering,Inc. Latest Developments
13.17 Wuhan Hvsen Biotechnology CO.,LTD
13.17.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
13.17.2 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.17.3 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Wuhan Hvsen Biotechnology CO.,LTD Main Business Overview
13.17.5 Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
13.18 Jinhe Biotechnology Co., Ltd.
13.18.1 Jinhe Biotechnology Co., Ltd. Company Information
13.18.2 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.18.3 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Jinhe Biotechnology Co., Ltd. Main Business Overview
13.18.5 Jinhe Biotechnology Co., Ltd. Latest Developments
13.19 Shanghai Shen Lian Biomedical Corporation
13.19.1 Shanghai Shen Lian Biomedical Corporation Company Information
13.19.2 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.19.3 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Shanghai Shen Lian Biomedical Corporation Main Business Overview
13.19.5 Shanghai Shen Lian Biomedical Corporation Latest Developments
13.20 Qingdao Vland Biotech INC.
13.20.1 Qingdao Vland Biotech INC. Company Information
13.20.2 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.20.3 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Qingdao Vland Biotech INC. Main Business Overview
13.20.5 Qingdao Vland Biotech INC. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Veterinary Genetic Engineering Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Veterinary Genetic Engineering Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Veterinary Genetic Engineering Vaccines Segment by Type
2.2.1 Genetic Recombinant Vaccine
2.2.2 Recombinant Subunit Vaccines
2.2.3 Genetic Vaccine
2.3 Veterinary Genetic Engineering Vaccines Sales by Type
2.3.1 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Veterinary Genetic Engineering Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Type (2018-2023)
2.4 Veterinary Genetic Engineering Vaccines Segment by Application
2.4.1 Poultry
2.4.2 Livestock
2.4.3 Other
2.5 Veterinary Genetic Engineering Vaccines Sales by Application
2.5.1 Global Veterinary Genetic Engineering Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Veterinary Genetic Engineering Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Application (2018-2023)
3 GLOBAL VETERINARY GENETIC ENGINEERING VACCINES BY COMPANY
3.1 Global Veterinary Genetic Engineering Vaccines Breakdown Data by Company
3.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Veterinary Genetic Engineering Vaccines Revenue by Company (2018-2023)
3.2.2 Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Veterinary Genetic Engineering Vaccines Sale Price by Company
3.4 Key Manufacturers Veterinary Genetic Engineering Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Genetic Engineering Vaccines Product Location Distribution
3.4.2 Players Veterinary Genetic Engineering Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VETERINARY GENETIC ENGINEERING VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Genetic Engineering Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Veterinary Genetic Engineering Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Veterinary Genetic Engineering Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Veterinary Genetic Engineering Vaccines Sales Growth
4.4 APAC Veterinary Genetic Engineering Vaccines Sales Growth
4.5 Europe Veterinary Genetic Engineering Vaccines Sales Growth
4.6 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Growth
5 AMERICAS
5.1 Americas Veterinary Genetic Engineering Vaccines Sales by Country
5.1.1 Americas Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023)
5.1.2 Americas Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023)
5.2 Americas Veterinary Genetic Engineering Vaccines Sales by Type
5.3 Americas Veterinary Genetic Engineering Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Genetic Engineering Vaccines Sales by Region
6.1.1 APAC Veterinary Genetic Engineering Vaccines Sales by Region (2018-2023)
6.1.2 APAC Veterinary Genetic Engineering Vaccines Revenue by Region (2018-2023)
6.2 APAC Veterinary Genetic Engineering Vaccines Sales by Type
6.3 APAC Veterinary Genetic Engineering Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Genetic Engineering Vaccines by Country
7.1.1 Europe Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023)
7.1.2 Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023)
7.2 Europe Veterinary Genetic Engineering Vaccines Sales by Type
7.3 Europe Veterinary Genetic Engineering Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Genetic Engineering Vaccines by Country
8.1.1 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Type
8.3 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Genetic Engineering Vaccines
10.3 Manufacturing Process Analysis of Veterinary Genetic Engineering Vaccines
10.4 Industry Chain Structure of Veterinary Genetic Engineering Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Genetic Engineering Vaccines Distributors
11.3 Veterinary Genetic Engineering Vaccines Customer
12 WORLD FORECAST REVIEW FOR VETERINARY GENETIC ENGINEERING VACCINES BY GEOGRAPHIC REGION
12.1 Global Veterinary Genetic Engineering Vaccines Market Size Forecast by Region
12.1.1 Global Veterinary Genetic Engineering Vaccines Forecast by Region (2024-2029)
12.1.2 Global Veterinary Genetic Engineering Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary Genetic Engineering Vaccines Forecast by Type
12.7 Global Veterinary Genetic Engineering Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.1.3 Merck Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.2.3 GSK Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.3.3 Sanofi Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Zoties
13.4.1 Zoties Company Information
13.4.2 Zoties Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.4.3 Zoties Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zoties Main Business Overview
13.4.5 Zoties Latest Developments
13.5 Elanco
13.5.1 Elanco Company Information
13.5.2 Elanco Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.5.3 Elanco Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Elanco Main Business Overview
13.5.5 Elanco Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Indian Immunologicals
13.7.1 Indian Immunologicals Company Information
13.7.2 Indian Immunologicals Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.7.3 Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Indian Immunologicals Main Business Overview
13.7.5 Indian Immunologicals Latest Developments
13.8 China Animal Husbandry Industry Co.,Ltd.
13.8.1 China Animal Husbandry Industry Co.,Ltd. Company Information
13.8.2 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.8.3 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 China Animal Husbandry Industry Co.,Ltd. Main Business Overview
13.8.5 China Animal Husbandry Industry Co.,Ltd. Latest Developments
13.9 Yebio Bioengineering Co., Ltd Of Qingdao
13.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
13.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Main Business Overview
13.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
13.10 Jinyu Bio-technology Co.,ltd.
13.10.1 Jinyu Bio-technology Co.,ltd. Company Information
13.10.2 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.10.3 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jinyu Bio-technology Co.,ltd. Main Business Overview
13.10.5 Jinyu Bio-technology Co.,ltd. Latest Developments
13.11 HVRI
13.11.1 HVRI Company Information
13.11.2 HVRI Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.11.3 HVRI Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 HVRI Main Business Overview
13.11.5 HVRI Latest Developments
13.12 Ringpu Biology
13.12.1 Ringpu Biology Company Information
13.12.2 Ringpu Biology Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.12.3 Ringpu Biology Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ringpu Biology Main Business Overview
13.12.5 Ringpu Biology Latest Developments
13.13 Kyoto Biken Laboratories
13.13.1 Kyoto Biken Laboratories Company Information
13.13.2 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.13.3 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Kyoto Biken Laboratories Main Business Overview
13.13.5 Kyoto Biken Laboratories Latest Developments
13.14 FATRO
13.14.1 FATRO Company Information
13.14.2 FATRO Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.14.3 FATRO Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 FATRO Main Business Overview
13.14.5 FATRO Latest Developments
13.15 Ceva Sant? Animale
13.15.1 Ceva Sant? Animale Company Information
13.15.2 Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.15.3 Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Ceva Sant? Animale Main Business Overview
13.15.5 Ceva Sant? Animale Latest Developments
13.16 Pulike Biological Engineering,Inc.
13.16.1 Pulike Biological Engineering,Inc. Company Information
13.16.2 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.16.3 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Pulike Biological Engineering,Inc. Main Business Overview
13.16.5 Pulike Biological Engineering,Inc. Latest Developments
13.17 Wuhan Hvsen Biotechnology CO.,LTD
13.17.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
13.17.2 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.17.3 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Wuhan Hvsen Biotechnology CO.,LTD Main Business Overview
13.17.5 Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
13.18 Jinhe Biotechnology Co., Ltd.
13.18.1 Jinhe Biotechnology Co., Ltd. Company Information
13.18.2 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.18.3 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Jinhe Biotechnology Co., Ltd. Main Business Overview
13.18.5 Jinhe Biotechnology Co., Ltd. Latest Developments
13.19 Shanghai Shen Lian Biomedical Corporation
13.19.1 Shanghai Shen Lian Biomedical Corporation Company Information
13.19.2 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.19.3 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Shanghai Shen Lian Biomedical Corporation Main Business Overview
13.19.5 Shanghai Shen Lian Biomedical Corporation Latest Developments
13.20 Qingdao Vland Biotech INC.
13.20.1 Qingdao Vland Biotech INC. Company Information
13.20.2 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
13.20.3 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Qingdao Vland Biotech INC. Main Business Overview
13.20.5 Qingdao Vland Biotech INC. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Veterinary Genetic Engineering Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Veterinary Genetic Engineering Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Genetic Recombinant Vaccine
Table 4. Major Players of Recombinant Subunit Vaccines
Table 5. Major Players of Genetic Vaccine
Table 6. Global Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023) & (K Units)
Table 7. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Table 8. Global Veterinary Genetic Engineering Vaccines Revenue by Type (2018-2023) & ($ million)
Table 9. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2018-2023)
Table 10. Global Veterinary Genetic Engineering Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023) & (K Units)
Table 12. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Table 13. Global Veterinary Genetic Engineering Vaccines Revenue by Application (2018-2023)
Table 14. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application (2018-2023)
Table 15. Global Veterinary Genetic Engineering Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Veterinary Genetic Engineering Vaccines Sales by Company (2018-2023) & (K Units)
Table 17. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company (2018-2023)
Table 18. Global Veterinary Genetic Engineering Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company (2018-2023)
Table 20. Global Veterinary Genetic Engineering Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Veterinary Genetic Engineering Vaccines Producing Area Distribution and Sales Area
Table 22. Players Veterinary Genetic Engineering Vaccines Products Offered
Table 23. Veterinary Genetic Engineering Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Veterinary Genetic Engineering Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Veterinary Genetic Engineering Vaccines Sales Market Share Geographic Region (2018-2023)
Table 28. Global Veterinary Genetic Engineering Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Veterinary Genetic Engineering Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Country/Region (2018-2023)
Table 32. Global Veterinary Genetic Engineering Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 35. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2023)
Table 36. Americas Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2023)
Table 38. Americas Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023) & (K Units)
Table 39. Americas Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023) & (K Units)
Table 40. APAC Veterinary Genetic Engineering Vaccines Sales by Region (2018-2023) & (K Units)
Table 41. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Region (2018-2023)
Table 42. APAC Veterinary Genetic Engineering Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Veterinary Genetic Engineering Vaccines Revenue Market Share by Region (2018-2023)
Table 44. APAC Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023) & (K Units)
Table 45. APAC Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023) & (K Units)
Table 46. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2023)
Table 48. Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2023)
Table 50. Europe Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023) & (K Units)
Table 51. Europe Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Veterinary Genetic Engineering Vaccines
Table 59. Key Market Challenges & Risks of Veterinary Genetic Engineering Vaccines
Table 60. Key Industry Trends of Veterinary Genetic Engineering Vaccines
Table 61. Veterinary Genetic Engineering Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Veterinary Genetic Engineering Vaccines Distributors List
Table 64. Veterinary Genetic Engineering Vaccines Customer List
Table 65. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Veterinary Genetic Engineering Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Veterinary Genetic Engineering Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Veterinary Genetic Engineering Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Veterinary Genetic Engineering Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 81. Merck Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. GSK Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 86. GSK Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. Sanofi Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Sanofi Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 91. Sanofi Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Sanofi Main Business
Table 93. Sanofi Latest Developments
Table 94. Zoties Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Zoties Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 96. Zoties Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Zoties Main Business
Table 98. Zoties Latest Developments
Table 99. Elanco Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Elanco Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 101. Elanco Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Elanco Main Business
Table 103. Elanco Latest Developments
Table 104. Boehringer Ingelheim Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 106. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Boehringer Ingelheim Main Business
Table 108. Boehringer Ingelheim Latest Developments
Table 109. Indian Immunologicals Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Indian Immunologicals Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 111. Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Indian Immunologicals Main Business
Table 113. Indian Immunologicals Latest Developments
Table 114. China Animal Husbandry Industry Co.,Ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 116. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. China Animal Husbandry Industry Co.,Ltd. Main Business
Table 118. China Animal Husbandry Industry Co.,Ltd. Latest Developments
Table 119. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 121. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Yebio Bioengineering Co., Ltd Of Qingdao Main Business
Table 123. Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
Table 124. Jinyu Bio-technology Co.,ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 126. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Jinyu Bio-technology Co.,ltd. Main Business
Table 128. Jinyu Bio-technology Co.,ltd. Latest Developments
Table 129. HVRI Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. HVRI Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 131. HVRI Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. HVRI Main Business
Table 133. HVRI Latest Developments
Table 134. Ringpu Biology Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 135. Ringpu Biology Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 136. Ringpu Biology Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Ringpu Biology Main Business
Table 138. Ringpu Biology Latest Developments
Table 139. Kyoto Biken Laboratories Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 140. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 141. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Kyoto Biken Laboratories Main Business
Table 143. Kyoto Biken Laboratories Latest Developments
Table 144. FATRO Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 145. FATRO Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 146. FATRO Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. FATRO Main Business
Table 148. FATRO Latest Developments
Table 149. Ceva Sant? Animale Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 150. Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 151. Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Ceva Sant? Animale Main Business
Table 153. Ceva Sant? Animale Latest Developments
Table 154. Pulike Biological Engineering,Inc. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 155. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 156. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Pulike Biological Engineering,Inc. Main Business
Table 158. Pulike Biological Engineering,Inc. Latest Developments
Table 159. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 160. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 161. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Wuhan Hvsen Biotechnology CO.,LTD Main Business
Table 163. Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
Table 164. Jinhe Biotechnology Co., Ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 165. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 166. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Jinhe Biotechnology Co., Ltd. Main Business
Table 168. Jinhe Biotechnology Co., Ltd. Latest Developments
Table 169. Shanghai Shen Lian Biomedical Corporation Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 170. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 171. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. Shanghai Shen Lian Biomedical Corporation Main Business
Table 173. Shanghai Shen Lian Biomedical Corporation Latest Developments
Table 174. Qingdao Vland Biotech INC. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 175. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 176. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 177. Qingdao Vland Biotech INC. Main Business
Table 178. Qingdao Vland Biotech INC. Latest Developments
Table 1. Veterinary Genetic Engineering Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Veterinary Genetic Engineering Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Genetic Recombinant Vaccine
Table 4. Major Players of Recombinant Subunit Vaccines
Table 5. Major Players of Genetic Vaccine
Table 6. Global Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023) & (K Units)
Table 7. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Table 8. Global Veterinary Genetic Engineering Vaccines Revenue by Type (2018-2023) & ($ million)
Table 9. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2018-2023)
Table 10. Global Veterinary Genetic Engineering Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023) & (K Units)
Table 12. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Table 13. Global Veterinary Genetic Engineering Vaccines Revenue by Application (2018-2023)
Table 14. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application (2018-2023)
Table 15. Global Veterinary Genetic Engineering Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Veterinary Genetic Engineering Vaccines Sales by Company (2018-2023) & (K Units)
Table 17. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company (2018-2023)
Table 18. Global Veterinary Genetic Engineering Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company (2018-2023)
Table 20. Global Veterinary Genetic Engineering Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Veterinary Genetic Engineering Vaccines Producing Area Distribution and Sales Area
Table 22. Players Veterinary Genetic Engineering Vaccines Products Offered
Table 23. Veterinary Genetic Engineering Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Veterinary Genetic Engineering Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Veterinary Genetic Engineering Vaccines Sales Market Share Geographic Region (2018-2023)
Table 28. Global Veterinary Genetic Engineering Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Veterinary Genetic Engineering Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Country/Region (2018-2023)
Table 32. Global Veterinary Genetic Engineering Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 35. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2023)
Table 36. Americas Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2023)
Table 38. Americas Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023) & (K Units)
Table 39. Americas Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023) & (K Units)
Table 40. APAC Veterinary Genetic Engineering Vaccines Sales by Region (2018-2023) & (K Units)
Table 41. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Region (2018-2023)
Table 42. APAC Veterinary Genetic Engineering Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Veterinary Genetic Engineering Vaccines Revenue Market Share by Region (2018-2023)
Table 44. APAC Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023) & (K Units)
Table 45. APAC Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023) & (K Units)
Table 46. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2023)
Table 48. Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2023)
Table 50. Europe Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023) & (K Units)
Table 51. Europe Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Veterinary Genetic Engineering Vaccines
Table 59. Key Market Challenges & Risks of Veterinary Genetic Engineering Vaccines
Table 60. Key Industry Trends of Veterinary Genetic Engineering Vaccines
Table 61. Veterinary Genetic Engineering Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Veterinary Genetic Engineering Vaccines Distributors List
Table 64. Veterinary Genetic Engineering Vaccines Customer List
Table 65. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Veterinary Genetic Engineering Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Veterinary Genetic Engineering Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Veterinary Genetic Engineering Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Veterinary Genetic Engineering Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Veterinary Genetic Engineering Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Veterinary Genetic Engineering Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 81. Merck Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. GSK Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 86. GSK Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. Sanofi Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Sanofi Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 91. Sanofi Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Sanofi Main Business
Table 93. Sanofi Latest Developments
Table 94. Zoties Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Zoties Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 96. Zoties Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Zoties Main Business
Table 98. Zoties Latest Developments
Table 99. Elanco Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Elanco Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 101. Elanco Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Elanco Main Business
Table 103. Elanco Latest Developments
Table 104. Boehringer Ingelheim Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 106. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Boehringer Ingelheim Main Business
Table 108. Boehringer Ingelheim Latest Developments
Table 109. Indian Immunologicals Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Indian Immunologicals Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 111. Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Indian Immunologicals Main Business
Table 113. Indian Immunologicals Latest Developments
Table 114. China Animal Husbandry Industry Co.,Ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 116. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. China Animal Husbandry Industry Co.,Ltd. Main Business
Table 118. China Animal Husbandry Industry Co.,Ltd. Latest Developments
Table 119. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 121. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Yebio Bioengineering Co., Ltd Of Qingdao Main Business
Table 123. Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
Table 124. Jinyu Bio-technology Co.,ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 126. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Jinyu Bio-technology Co.,ltd. Main Business
Table 128. Jinyu Bio-technology Co.,ltd. Latest Developments
Table 129. HVRI Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. HVRI Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 131. HVRI Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. HVRI Main Business
Table 133. HVRI Latest Developments
Table 134. Ringpu Biology Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 135. Ringpu Biology Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 136. Ringpu Biology Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Ringpu Biology Main Business
Table 138. Ringpu Biology Latest Developments
Table 139. Kyoto Biken Laboratories Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 140. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 141. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Kyoto Biken Laboratories Main Business
Table 143. Kyoto Biken Laboratories Latest Developments
Table 144. FATRO Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 145. FATRO Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 146. FATRO Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. FATRO Main Business
Table 148. FATRO Latest Developments
Table 149. Ceva Sant? Animale Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 150. Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 151. Ceva Sant? Animale Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Ceva Sant? Animale Main Business
Table 153. Ceva Sant? Animale Latest Developments
Table 154. Pulike Biological Engineering,Inc. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 155. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 156. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Pulike Biological Engineering,Inc. Main Business
Table 158. Pulike Biological Engineering,Inc. Latest Developments
Table 159. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 160. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 161. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Wuhan Hvsen Biotechnology CO.,LTD Main Business
Table 163. Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
Table 164. Jinhe Biotechnology Co., Ltd. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 165. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 166. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Jinhe Biotechnology Co., Ltd. Main Business
Table 168. Jinhe Biotechnology Co., Ltd. Latest Developments
Table 169. Shanghai Shen Lian Biomedical Corporation Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 170. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 171. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. Shanghai Shen Lian Biomedical Corporation Main Business
Table 173. Shanghai Shen Lian Biomedical Corporation Latest Developments
Table 174. Qingdao Vland Biotech INC. Basic Information, Veterinary Genetic Engineering Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 175. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product Portfolios and Specifications
Table 176. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 177. Qingdao Vland Biotech INC. Main Business
Table 178. Qingdao Vland Biotech INC. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Veterinary Genetic Engineering Vaccines
Figure 2. Veterinary Genetic Engineering Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Genetic Engineering Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Veterinary Genetic Engineering Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Veterinary Genetic Engineering Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Genetic Recombinant Vaccine
Figure 10. Product Picture of Recombinant Subunit Vaccines
Figure 11. Product Picture of Genetic Vaccine
Figure 12. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type in 2022
Figure 13. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2018-2023)
Figure 14. Veterinary Genetic Engineering Vaccines Consumed in Poultry
Figure 15. Global Veterinary Genetic Engineering Vaccines Market: Poultry (2018-2023) & (K Units)
Figure 16. Veterinary Genetic Engineering Vaccines Consumed in Livestock
Figure 17. Global Veterinary Genetic Engineering Vaccines Market: Livestock (2018-2023) & (K Units)
Figure 18. Veterinary Genetic Engineering Vaccines Consumed in Other
Figure 19. Global Veterinary Genetic Engineering Vaccines Market: Other (2018-2023) & (K Units)
Figure 20. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2022)
Figure 21. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application in 2022
Figure 22. Veterinary Genetic Engineering Vaccines Sales Market by Company in 2022 (K Units)
Figure 23. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company in 2022
Figure 24. Veterinary Genetic Engineering Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company in 2022
Figure 26. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Veterinary Genetic Engineering Vaccines Sales 2018-2023 (K Units)
Figure 29. Americas Veterinary Genetic Engineering Vaccines Revenue 2018-2023 ($ Millions)
Figure 30. APAC Veterinary Genetic Engineering Vaccines Sales 2018-2023 (K Units)
Figure 31. APAC Veterinary Genetic Engineering Vaccines Revenue 2018-2023 ($ Millions)
Figure 32. Europe Veterinary Genetic Engineering Vaccines Sales 2018-2023 (K Units)
Figure 33. Europe Veterinary Genetic Engineering Vaccines Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue 2018-2023 ($ Millions)
Figure 36. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Country in 2022
Figure 37. Americas Veterinary Genetic Engineering Vaccines Revenue Market Share by Country in 2022
Figure 38. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Figure 39. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Figure 40. United States Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Region in 2022
Figure 45. APAC Veterinary Genetic Engineering Vaccines Revenue Market Share by Regions in 2022
Figure 46. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Figure 47. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Figure 48. China Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Country in 2022
Figure 56. Europe Veterinary Genetic Engineering Vaccines Revenue Market Share by Country in 2022
Figure 57. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Figure 58. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Figure 59. Germany Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Figure 68. Egypt Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Veterinary Genetic Engineering Vaccines in 2022
Figure 74. Manufacturing Process Analysis of Veterinary Genetic Engineering Vaccines
Figure 75. Industry Chain Structure of Veterinary Genetic Engineering Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Veterinary Genetic Engineering Vaccines Sales Market Forecast by Region (2024-2029)
Figure 78. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Veterinary Genetic Engineering Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Veterinary Genetic Engineering Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Veterinary Genetic Engineering Vaccines
Figure 2. Veterinary Genetic Engineering Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Genetic Engineering Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Veterinary Genetic Engineering Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Veterinary Genetic Engineering Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Genetic Recombinant Vaccine
Figure 10. Product Picture of Recombinant Subunit Vaccines
Figure 11. Product Picture of Genetic Vaccine
Figure 12. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type in 2022
Figure 13. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2018-2023)
Figure 14. Veterinary Genetic Engineering Vaccines Consumed in Poultry
Figure 15. Global Veterinary Genetic Engineering Vaccines Market: Poultry (2018-2023) & (K Units)
Figure 16. Veterinary Genetic Engineering Vaccines Consumed in Livestock
Figure 17. Global Veterinary Genetic Engineering Vaccines Market: Livestock (2018-2023) & (K Units)
Figure 18. Veterinary Genetic Engineering Vaccines Consumed in Other
Figure 19. Global Veterinary Genetic Engineering Vaccines Market: Other (2018-2023) & (K Units)
Figure 20. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2022)
Figure 21. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application in 2022
Figure 22. Veterinary Genetic Engineering Vaccines Sales Market by Company in 2022 (K Units)
Figure 23. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Company in 2022
Figure 24. Veterinary Genetic Engineering Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Company in 2022
Figure 26. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Veterinary Genetic Engineering Vaccines Sales 2018-2023 (K Units)
Figure 29. Americas Veterinary Genetic Engineering Vaccines Revenue 2018-2023 ($ Millions)
Figure 30. APAC Veterinary Genetic Engineering Vaccines Sales 2018-2023 (K Units)
Figure 31. APAC Veterinary Genetic Engineering Vaccines Revenue 2018-2023 ($ Millions)
Figure 32. Europe Veterinary Genetic Engineering Vaccines Sales 2018-2023 (K Units)
Figure 33. Europe Veterinary Genetic Engineering Vaccines Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue 2018-2023 ($ Millions)
Figure 36. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Country in 2022
Figure 37. Americas Veterinary Genetic Engineering Vaccines Revenue Market Share by Country in 2022
Figure 38. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Figure 39. Americas Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Figure 40. United States Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Region in 2022
Figure 45. APAC Veterinary Genetic Engineering Vaccines Revenue Market Share by Regions in 2022
Figure 46. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Figure 47. APAC Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Figure 48. China Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Country in 2022
Figure 56. Europe Veterinary Genetic Engineering Vaccines Revenue Market Share by Country in 2022
Figure 57. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Figure 58. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Figure 59. Germany Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Figure 68. Egypt Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Veterinary Genetic Engineering Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Veterinary Genetic Engineering Vaccines in 2022
Figure 74. Manufacturing Process Analysis of Veterinary Genetic Engineering Vaccines
Figure 75. Industry Chain Structure of Veterinary Genetic Engineering Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Veterinary Genetic Engineering Vaccines Sales Market Forecast by Region (2024-2029)
Figure 78. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Veterinary Genetic Engineering Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Veterinary Genetic Engineering Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Veterinary Genetic Engineering Vaccines Revenue Market Share Forecast by Application (2024-2029)
